-       Report 
- October 2025
-  197 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- November 2025
-  382 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- March 2025
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- September 2023
-  98 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
           -       Report 
- April 2024
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
             The Cancer Immunotherapy Drug Discovery Outsourcing market is a subset of the larger Drug Discovery market. It focuses on the development of drugs that use the body's own immune system to fight cancer. This includes the development of monoclonal antibodies, small molecules, and other immunotherapies. Companies in this market provide services such as target identification, lead optimization, preclinical development, and clinical trial support.
Companies in the Cancer Immunotherapy Drug Discovery    Outsourcing market include Charles River Laboratories, WuXi AppTec, Parexel, and Syngene International. Other companies in the Drug Discovery market include Evotec, Almac Group, and Piramal Pharma Solutions. Show Less   Read more